A Phase 4 interventional study of Heparin injection in Mesenteric Ischemia, sponsored by Mansoura University. Completed at 1 site in Egypt. Open to participants aged 16 Years to 85 Years. Per ClinicalTrials.gov, last updated 2017-08-29.
Sponsored by Mansoura University · Phase 4, Interventional, and Diagnostic
The study aims to identify several factors that can accurately predict the incident of intestinal infraction in patients with mesenteric vascular occlusion or ischemia.
The study aims to identify several clinical, laboratory, and radiologic factors that can accurately predict the occurrence of intestinal infraction in patients with mesenteric vascular occlusion or ischemia in order to prevent unnecessary surgical intervention in patients with just intestinal ischemia and to hasten intervention in patients with actual intestinal gangrene.
40 studies on the registry are indexed under Mesenteric Ischemia; 14 are open to participants now.
This study's enrollment of 97 is below the median of 110 across 14 interventional studies indexed under Mesenteric Ischemia.
Browse Mesenteric Ischemia studies →Mansoura University is the lead sponsor of 1,119 studies on the registry; 183 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Injection of low molecular weight heparin in patients with acute mesenteric ischemia to assess outcome
Drug: Heparin injection
Intravenous heparin injection in patients with acute mesenteric ischemia and evaluating their response within 24 hours
Also known as: Low molecular weight heparin injection
Clinical improvement
Number of patients with resolved abdominal symptoms and incidence of patients developing shock
Time frame: 48 hours
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Heparin